Zoetis, Inc.

Zoetis, Inc.

Zoetis, Inc.

Overview
Date Founded

1952

Type of Company

Public

Employees (Worldwide)

10K

Industries

Pharmaceuticals
Market & Policy Research
Hospitals & Patient Services
Biotechnology

Company Description

Zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways. Building on more than 65 years of experience, we deliver quality medicines, vaccines and diagnostic products, complemented by genetic tests, biodevices and a range of services. We are working every day to better understand and address the real-world challenges faced by those who raise and care for animals in ways they find truly relevant.

Contact Data
Trying to get in touch with decision makers at Zoetis, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Executive Vice President & Chief Financial Officer

Executive Vice President & General Counsel

Executive Vice President, Chief Digital & Technology Officer

Executive Vice President & Chief Human Resources Officer

President, Global Manufacturing & Supply

Executive Vice President & Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health & Human Diagnostics

Executive Vice President & Group President, US Operations, Business Development & Strategy

Executive Vice President & President, Research & Development

President

Board of Directors

Former Chief Executive Officer at Humana, Inc.

Chief Financial Officer & Executive Vice President, Global Supply & Business Operations at Pfizer, Inc.

Former Co-President at Morgan Stanley

Of Counsel at Cleary Gottlieb Steen & Hamilton LLP

Former Senior Consultant at Arthur Andersen LLP

Vice Chairman & President at The New York Botanical Garden

Managing Director at G9 Capital Group LLC

Chief Executive Officer at Zoetis, Inc.

Dean at Purdue University

Former CSO at Aratana Therapeutics, Inc.

Paths to Zoetis, Inc.
Potential Connections via
Relationship Science
You
Zoetis, Inc.
Owners & Shareholders
Details Hidden

AB's investment analysts create proprietary research to support our portfolio managers, who also can conduct their own research. Their portfolio management professionals then implement our discretionary investment strategies. The firm's professionals employ a range of investment strategies to implement the advice they give to clients including: long-term purchases, short-term purchases, trading, short sales, margin transactions, option strategies including writing covered options, uncovered options and spread strategies, and taking advantage of price differentials between two or more securities (arbitrage). Quantitative analytics are utilized in some of AB's investment activities, to assist in the selection of securities or the management of investment risk. It is often necessary for them to acquire or dispose of the same securities for more than one client account at the same time. In conducting security analysis, they utilize a broad spectrum of information, including without limitation financial publications, third-party research materials, annual reports, prospectuses, regulatory filings, company press releases, corporate rating services, inspections of corporate activities and meetings with management of various companies.

Details Hidden

State Farm® has been in the mutual funds business since 1968, managing funds then only available to employees and Agents. In 2001, State Farm Mutual Funds products and services became available to the public for the first time. Our main objective is to make each of our 15 State Farm Mutual Funds® a highly competitive and rewarding long-term investment for our shareholders. To help achieve this objective, we use an investment management structure that capitalizes on the unique strengths, focused attention, and knowledge of seasoned investment professionals in State Farm’s internal investment department. Because we offer a wide variety of funds, some outside the core knowledge of our internal investment department, we also have seven other highly-respected asset management organizations working for you. Each of our investment advisors provides well-known, long-established experts in their respective investment strategies and has beliefs and investment philosophies that are consistent with our own. State Farm Mutual Funds shareholders can feel confident that their investments are being managed in a responsible, conservative, and cost-effective manner consistent with a long-term perspective

Details Hidden

Polen Capital employs a disciplined, bottom-up, concentrated US, Global and International equity investment strategies that focus on high quality growth investments. The Polen Focus Growth strategy invests in a concentrated portfolio of primarily large-cap US common stocks with sustainable competitive advantages. The Polen Global Growth strategy invests in a concentrated portfolio of outstanding US and international businesses with competitive advantages and the potential for sustained superior growth. It emphasizes sustainable earnings growth and focuses on companies with high returns on capital and double digit earnings growth. The Polen International Growth strategy applies the same philosophy as the Focus Growth and Global Growth portfolios, but invests exclusively in businesses domiciled outside of the US.

Recent Transactions
Details Hidden

Zoetis, Inc. purchases Platinum Performance, Inc.

Details Hidden

Zoetis, Inc. purchases ABAXIS, Inc.

Details Hidden

Zoetis, Inc. purchases Smartbow GmbH from OÖ Hightechfonds GmbH

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Investment Advisor

Advised onYung Shin Pharmaceutical Industrial Co., Ltd., YungShin Global Holding Corp. purchase Zoetis, Inc. /Hsinchu Manufacturing Site Ops from Zoetis, Inc.

Underwriter

Advised onZoetis, Inc. issued USD Common Stock

Underwriter

Advised onZoetis, Inc. issued USD Common Stock

Analyst Tokyo

Advised onNippon Soda Co., Ltd. purchases from Zoetis, Inc.

Co-Chair, Corporate Group

Advised onZoetis, Inc. purchases ABAXIS, Inc.

Legal Advisor

Advised onZoetis, Inc., Zoetis Belgium SA purchase Nexvet Biopharma Plc

Advisors & Consultants
Advisor

Executive Vice President & Chief Financial Officer at Valeant Pharmaceuticals International Corp.

Legal Advisor

Partner at Davis Polk & Wardwell LLP

Legal Advisor

Honorary Professor at University of Glasgow

Clients

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Covetrus, Inc. engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals. The company was founded on April 13, 2018 and is headquartered in Melville, NY.

ABAXIS, Inc. engages in the development, manufacture, and marketing of portable blood analysis systems. It operates through the following segments: Medical Market, Veterinary Market, and Other. The Medical Market segment serves a customer group consisting of physicians' office practices across multiple specialties, urgent care, outpatient and walk-in clinics, health screening operations, home care providers, nursing homes, ambulance companies, oncology treatment clinics, dialysis centers, pharmacies, hospital laboratories, military installations, pharmaceutical clinical trials, and cruise ship lines. The Veterinary Market segment focuses on animal hospitals, animal clinics with mixed practices of small animals, birds and reptiles, equine and bovine practitioners, veterinary emergency clinics, veterinary referral hospitals, universities, government, pharmaceutical companies, biotechnology companies, and private research laboratories. The company was founded by Vladimir E. Ostoich in April 1989 and is headquartered in Union City, CA.

Key Stats and Financials As of 2018
Market Capitalization
$54.6B
Total Enterprise Value
$46.4B
Earnings Per Share
$2.93
Revenue
$5.82B
Net Profit
$1.43B
EBITDA
$2.19B
EBITDAMargin
37.58%
Total Debt
$6.45B
Total Equity
$2.18B
Enterprise Value Sales
7.97x
Enterprise Value EBITDAOperating
21.2x
TEVNet Income
32.49x
Debt TEV
0.14x
Three Year Compounded Annual Growth Rate Of Revenue
6.92%
Five Year Compounded Annual Growth Rate Of Revenue
5.01%
Non-Profit Donations & Grants
Investors
Details Hidden

Co-Founder at Pershing Square Foundation

Suppliers
IMV, Inc. Biotechnology | Dartmouth, NS

IMV, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of cancer immunotherapies and infectious disease vaccines. The firm's patented platform, DepoVax, provides controlled and prolonged exposure of antigens and adjuvant to the immune system. The company was founded by Warwick Kimmins and Brian E. Lowe on March 28, 2000 and is headquartered in Dartmouth, Canada.

Pfizer, Inc. Medical Support Services | New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Where Food Comes From, Inc. Other Business & Consulting Services | Castle Rock, CO

Where Food Comes From, Inc. engages in the provision of food production audits. It uses rigorous verification processes to ensure that claims made by food producers and processors are accurate. It operates through the following segments: Verification and Certification, Software Sales and Related Consulting, and Other. The Verification and Certification segment sell validation solutions, consulting services, and hardware. The Software Sales and Related Consulting segment offers products via a SaaS model and web-hosting services. The company was founded by John Saunders and Leann Saunders in 1998 and is headquartered in Castle Rock, CO.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Elanco Animal Health, Inc. Livestock & Animals - Greenfield, IN

Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded on May 3, 2018 and is headquartered in Greenfield, IN.

Bayer AG Pharmaceuticals - Leverkusen, NW

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal year 2012, Bayer employed 110,500 people and had sales of €39.8 billion. Capital expenditures amounted to €2 billion, R&D expenses to €3 billion.

Awards & Honors
Rank #527
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Zoetis, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Zoetis, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Zoetis, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/zoetis-inc-494392
  • https://relationshipscience.com/organization/zoetis-inc-494392